Susan M. Welsh
President chez Linguagen Corp.
Profil
Susan M.
Welsh was the founder of Snowdon, Inc. founded in 2007 where she held the title of Chief Executive Officer from 2007 to 2013.
Currently, she holds positions as a Faculty Member at Stanford University, a Member-Advisory Board at the University of Washington, and as President of Linguagen Corp.
Dr. Welsh's former positions include Principal at ALZA Corp., Johnson & Johnson, Syntex Corp., GSK Plc, and Pharmacia Corp.
She also held the position of Group Vice President-Global Project Management at Schering-Plough Corp.
Additionally, she was the President of Robcor Properties, Inc. Dr. Welsh's education history includes a graduate degree from the University of Washington, an undergraduate degree from the University of Leeds, and an MBA from the University of California, Berkeley.
Postes actifs de Susan M. Welsh
| Sociétés | Poste | Début |
|---|---|---|
Linguagen Corp.
 Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | President | - |
| Stanford University | Corporate Officer/Principal | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Anciens postes connus de Susan M. Welsh
| Sociétés | Poste | Fin |
|---|---|---|
| Robcor Properties, Inc. | President | 30/03/2007 |
Snowdon, Inc.
 Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Directeur Général | - |
| GSK PLC | Corporate Officer/Principal | - |
| ALZA CORPORATION | Corporate Officer/Principal | - |
| Syntex Corp. | Corporate Officer/Principal | - |
Formation de Susan M. Welsh
| University of Washington | Graduate Degree |
| University of Leeds | Undergraduate Degree |
| University of California, Berkeley | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Syntex Corp. | Health Technology |
| Robcor Properties, Inc. | Finance |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Linguagen Corp.
Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Health Technology |
Snowdon, Inc.
Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Health Technology |
